Entrada Therapeutics
About Entrada Therapeutics
Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicle (EEV™) therapeutics, to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular diseases, immunology, oncology and diseases of the central nervous system. The Company’s lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD) and ENTR-701 targeting myotonic dystrophy type 1 (DM1).
Stock Symbol: TRDA
Stock Exchange: NASDAQ
CONNECT
“Most targets for drug development are actually intracellular,” says Dipal Doshi, President and CEO of Entrada Therapeutics. “Think about how many drugs can be made that can help patients if we can figure out a way to effectively get inside the cell…that’s why Entrada’s important.”
16 jobs with Entrada Therapeutics
-
Co-Op, Gene Editing
The organization: What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients'...
New
-
Director/Associate Director – Early Portfolio Management
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Director/Associate Director, Alliance Management
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Principal Scientist, Toxicology (ONSITE)
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Research Associate II, Neuromuscular and Cardiac Biology
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Research Associate, Process Chemistry (CONTRACT)
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Senior Vivarium Manager
What's happening at Entrada Therapeutics? Entrada's mission is to transform the treatment of devastating diseases with intracellular therapeutics. ...
-
Senior Scientist, Analytical Development
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Scientist II Invivo Neuromuscular
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Research Associate, Antisense Oligonucleotide (CONTRACT)
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Research Associate, Process Chemistry CONTRACT
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Senior Scientist/Principal Scientist – CMC Analytical and Quality Control
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Research Associate II/Senior RA, Bioanalytical Product Development
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Scientist, Platform Development (CONTRACT)
THE ORGANIZATION: What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients'...
-
Scientist, Oligonucleotide Process Chemistry (CONTRACT)
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...
-
Research Associate, Quantitative Biology - Contract
What's happening at Entrada Therapeutics? Our mission is to transform the treatment of devastating diseases and improve patients' quality of life u...